BioMarin Pharmaceutical Inc. (LON:0HNC)
London · Delayed Price · Currency is GBP · Price in USD 58.00
-1.30 (-2.19%)
At close: Jul 31, 2025
BioMarin Pharmaceutical Market Cap
BioMarin Pharmaceutical has a market cap or net worth of 8.42 billion as of August 1, 2025. Its market cap has decreased by -31.90% in one year.
Market Cap
8.42B
Enterprise Value
7.91B
Revenue
2.28B
Ranking
n/a
PE Ratio
20.76
Stock Price
58.00
Market Cap Chart
Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 283.77M to 8.42B, an increase of 2,866.32%. That is a compound annual growth rate of 13.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 8.42B | -15.88% |
| Dec 31, 2024 | 10.01B | -29.83% |
| Dec 29, 2023 | 14.26B | -10.67% |
| Dec 30, 2022 | 15.96B | 33.26% |
| Dec 31, 2021 | 11.98B | 2.74% |
| Dec 31, 2020 | 11.66B | 1.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 173.02B |
| GSK plc | 56.40B |
| Haleon | 32.99B |
| Smith & Nephew | 10.33B |
| ConvaTec Group | 5.00B |
| Hikma Pharmaceuticals | 4.36B |
| HUTCHMED (China) | 2.45B |
| Oxford Nanopore Technologies | 1.97B |